BVibe by Private Label Productions LLC PLP-COTR Delay Spray

BVibe by

Drug Labeling and Warnings

BVibe by is a Otc medication manufactured, distributed, or labeled by Private Label Productions LLC. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

BVIBE- lidocaine hcl delay spray liquid 
Private Label Productions LLC

----------

PLP-COTR Delay Spray

Active Ingredient(s)

Lidocaine HCl 9.94 mg

Purpose

Male Genital Desensitizer Topical Anesthetic

Use

Temporarily slows ejaculation onset for premature ejaculation management.

Warnings

For external use only.
Allergy alert: Avoid if allergic to lidocaine or other topical anesthetics.
Do Not Use: On broken/irritated/sensitive skin or if partner is pregnant.
When Using: Avoid eye contact; rinse if occurs.
Do not apply excessively to avoid side effects (e.g., numbness, irregular heartbeat).
Discontinue if rash, irritation, or burning occurs.
Stop Use and Consult a Doctor If: No relief, rash, irritation, or excessive numbness occurs.
Ask a Doctor Before Use If: You have liver/kidney issues or take interacting medications.
Keep Out of Reach of Children: Contact Poison Control if swallowed.
Other Warnings: Lidocaine may numb partner's mouth/throat during oral sex; allow 10 minutes absorption or wipe excess.
Overuse (>10 sprays) may cause numbness or erection loss.

Keep out of reach of childeren.Contact Poison Control if

Directions

Adults: Apply 3-10 sprays to penis head/shaft (focus on frenulum/tip) 10 minutes before intercourse.
Start with 3 sprays to assess sensitivity.
Shake bottle, spray directly or massage on.
Allow 10 minutes absorption; wipe excess before oral sex.
Wash off post-intercourse.

Store at 68°-77°F, away from heat/sunlight.

Other information

Inactive ingredients

Purified Water, Propanediol, Alcohol, Aloe Barbadensis Leaf Juice, Laureth 9, PEG 8, Panthenol, Panax Ginseng Root Extract, Hydroxyethy|cellulose, Menthyl Lactate, PPG-26-Buteth-26, PEG-40 Hydrogenated Castor Oil, Caprylyl Glycol, Phenoxyethanol, Ethylhexylglycerin

Package Label - Principal Display Panel

BVIBE 
lidocaine hcl delay spray liquid

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 77632-162
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
LIDOCAINE HYDROCHLORIDE (UNII: V13007Z41A) (LIDOCAINE - UNII:98PI200987)	LIDOCAINE HYDROCHLORIDE ANHYDROUS	9.94 mg  in 0.1 mL

Inactive Ingredients
Ingredient Name	Strength
CAPRYLYL GLYCOL (UNII: 00YIU5438U)
ETHYLHEXYLGLYCERIN (UNII: 147D247K3P)
ALOE BARBADENSIS LEAF JUICE (UNII: RUE8E6T4NB)
WATER (UNII: 059QF0KO0R)
HYDROXYETHYLCELLULOSE (UNII: T4V6TWG28D)
PEG-8 (UNII: B697894SGQ)
METHYL LACTATE (UNII: 0379G9C44S)
DECETH-7 (UNII: 4E11OV844J)
PROPANEDIOL (UNII: 5965N8W85T)
ASIAN GINSENG (UNII: CUQ3A77YXI)
PANTOTHENIC ACID (UNII: 19F5HK2737)
PHENOXYETHANOL (UNII: HIE492ZZ3T)
ALCOHOL (UNII: 3K9958V90M)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 77632-162-11	59 mL in 1 BOTTLE, SPRAY; Type 0: Not a Combination Product	07/15/2025

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	M017	07/15/2025

Labeler - Private Label Productions LLC (046278265)

Revised: 8/2025

Document Id: 3cf6cc19-092f-ba80-e063-6394a90a22dd

34390-5

Set id: 3cf6cc10-0bb4-b3b2-e063-6394a90a6c5b

Version: 1

Effective Time: 20250822